Impact of Metastasis Surgery and Alkylating-Agent-Based Chemotherapy on Outcomes of Metastatic Malignant Phyllodes Tumors: A Multicenter Retrospective Study - CNRS - Centre national de la recherche scientifique Accéder directement au contenu
Article Dans Une Revue Annals of Surgical Oncology Année : 2019

Impact of Metastasis Surgery and Alkylating-Agent-Based Chemotherapy on Outcomes of Metastatic Malignant Phyllodes Tumors: A Multicenter Retrospective Study

Christophe Sajous
  • Fonction : Auteur
Fabien Reyal
  • Fonction : Auteur
  • PersonId : 911231
Mehdi Brahmi
  • Fonction : Auteur
  • PersonId : 966414
Isabelle Ray-Coquard
Jean-Yves Blay
Nelly Firmin

Résumé

Metastatic phyllodes tumors have poor prognosis with median overall survival of 11.5 months. The objective of this study is to identify prognostic factors and the best options for management of metastatic malignant phyllode tumors (MMPTs).
Fichier non déposé

Dates et versions

hal-02530556 , version 1 (03-04-2020)

Identifiants

Citer

Mathias Neron, Christophe Sajous, Simon Thezenas, Sophie Piperno-Neumann, Fabien Reyal, et al.. Impact of Metastasis Surgery and Alkylating-Agent-Based Chemotherapy on Outcomes of Metastatic Malignant Phyllodes Tumors: A Multicenter Retrospective Study. Annals of Surgical Oncology, 2019, ⟨10.1245/s10434-019-08097-x⟩. ⟨hal-02530556⟩
32 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More